About Hurthle Cell Cancer
Hurthle cell cancer, or Hurthle cell carcinoma, is a rare type of thyroid cancer. It starts in Hurthle cells, a special type of cells in the thyroid gland that produce thyroid hormones.
This cancer is marked by abnormal Hurthle cells in the thyroid tissue. These cells are larger than normal thyroid cells and contain more mitochondria. The cancer can form nodules or tumors in the thyroid and may spread to nearby tissues or lymph nodes in the neck.
Diagnosing Hurthle cell cancer can be difficult because it looks similar to other thyroid problems. A combination of imaging tests, like ultrasound, and biopsy are usually needed to confirm the diagnosis. Treatment often involves surgery to remove the affected thyroid tissue, radioactive iodine therapy, and hormone replacement therapy.
If you suspect Hurthle cell cancer, it's important to speak with a healthcare provider for a proper diagnosis and treatment plan.
The root causes of Hurthle Cell Cancer (HCC) are not fully understood, but it is believed to be related to genetic mutations that cause abnormal growth of the Hurthle cells in the thyroid gland. These mutations can lead to uncontrolled cell division and the formation of tumors.
The non-modifiable risk factors for HCC are factors that cannot be changed. These include:
- Age: The risk of developing HCC increases with age, with most cases occurring in individuals over 60 years old.
- Gender: Women are more commonly affected by HCC compared to men.
The modifiable risk factors for HCC are factors that can be influenced or changed. These include:
- Radiation exposure: Previous exposure to radiation, such as radiation therapy to the head or neck during childhood, may increase the risk of developing thyroid cancer.
- Family history: Having a family history of thyroid cancer or certain genetic syndromes can increase the risk.
It's important to note that these risk factors do not guarantee the development of HCC, and many individuals without these risk factors can still develop the condition. Regular check-ups and screenings can help detect any abnormalities early on. If you have concerns about your risk factors or symptoms, consult with your healthcare professional for personalized advice.
The most common early symptoms of Hürthle cell thyroid cancer (HCC) include:
- Thyroid nodules and swelling of the lymph nodes in the neck.
- Larger nodules can cause a bump or lump in the neck that can be felt.
- Pain or discomfort in the front of the neck.
- Hoarseness, a tickle in the throat that may cause coughing.
- Difficulty swallowing and trouble breathing.
As HCC progresses or becomes more severe, additional symptoms may occur:
- Spread of cancer to other parts of the body, such as the lungs, bones, or liver.
- Fatigue, lack of appetite, weight loss, and general weakness.
- Neurological symptoms if it spreads to the brain.
- Fluid in the lungs and bone pain if it metastasizes to those areas.
It's important to note that symptoms can vary from person to person, and some individuals may not experience any symptoms at all. If you have any concerns or notice any changes in your health, it's best to consult with your healthcare professional for an accurate diagnosis and appropriate management.
To diagnose HCC, a variety of examinations, tests, and procedures may be performed. These can include:
- Clinical procedures: These are typically outpatient procedures that may require a referral from your primary care physician (PCP). They are performed on the path to a diagnosis.
- Laboratory (lab) tests: These tests involve checking samples of blood, urine, or body tissues to help diagnose the disease. The specific tests ordered will depend on your symptoms and the diseases being considered.
- Imaging studies: These studies allow doctors to look inside the body for clues to diagnose or manage the disease. The type of imaging study chosen depends on your symptoms and the part of the body being examined.
To determine the stage or severity of HCC, additional examinations, tests, and procedures may be recommended. These can include:
- Chest X-ray: This helps evaluate the organs and bones inside the chest.
- PET scan (positron emission tomography scan): This procedure is used to find malignant tumor cells in the body by injecting a small amount of radioactive glucose into a vein. The PET scanner then creates images that show areas where glucose is being used in the body.
- Bone scan: This procedure checks for rapidly dividing cells, such as cancer cells, in the bone.
It's important to consult with a doctor to discuss which examinations, tests, and procedures are appropriate for your individual situation.
The goals of treatment for HCC are to eliminate as many tumor cells as possible while preserving the function of adjacent normal tissues. The specific treatment options for HCC include:
- Surgery: The mainstay of treatment for HCC is surgery, which aims to remove the tumor and surrounding affected tissues. The extent of surgery depends on the stage and location of the cancer.
- Radioactive Iodine Therapy: After surgery, radioactive iodine therapy may be recommended to destroy any remaining cancer cells. This therapy works by using radioactive iodine to target and kill cancer cells that absorb iodine.
- External Beam Radiation Therapy: In some cases, external beam radiation therapy may be used to deliver high-energy radiation to the cancer site, destroying cancer cells and preventing their growth.
- Chemotherapy: Chemotherapy is a systemic treatment that uses drugs to destroy or slow down the growth of cancer cells. It may be used in cases where the cancer has spread beyond the thyroid.
- Targeted Therapy: Targeted therapy drugs specifically target certain molecules or pathways involved in cancer growth and progression. They may be used in cases where other treatments have not been effective.
In addition to these treatments, health behavior changes can support overall health and well-being during treatment. These are:
- Quitting smoking
- Maintaining a healthy diet
- Regular exercise
It's important to note that specific treatment recommendations for HCC should be discussed with a healthcare professional, as individual factors such as stage, extent of disease, and overall health can influence treatment decisions.